HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model.

Abstract
Vagus nerve stimulation (VNS) is an effective adjunctive treatment for medically refractory epilepsy. In this study, we measured VNS-induced changes in hippocampal neurotransmitter levels and determined their potential involvement in the anticonvulsive action of VNS, to elucidate the mechanism of action responsible for the seizure suppressing effect of VNS in an animal model for limbic seizures. We used in vivo intracerebral microdialysis to measure VNS-induced changes in hippocampal extracellular concentrations of noradrenaline, dopamine, serotonin and GABA in freely moving, male Wistar rats. During the same experiment, the effect of VNS on pilocarpine-induced limbic seizures was assessed using video-EEG monitoring. The involvement of VNS-induced increases in hippocampal noradrenaline in the mechanims of action of VNS was evaluated by blocking hippocampal α(2)-receptors. VNS produced a significant increase in hippocampal noradrenaline concentration (69 ± 16% above baseline levels). VNS also increased the latency between pilocarpine infusion and the onset of epileptiform discharges, and reduced the duration and severity of pilocarpine-induced limbic seizures. A strong positive correlation was found between the noradrenergic and anticonvulsive effects of VNS. Blockade of hippocampal α(2 -receptors reversed the seizure-suppressing effect of VNS. VNS induces increases in extracellular hippocampal noradrenaline, which are at least partly responsible for its seizure-suppressing effect in a model for limbic seizures, and constitute a potential biomarker for the efficacy of VNS in temporal lobe epilepsy.
AuthorsRobrecht Raedt, Ralph Clinckers, Lies Mollet, Kristl Vonck, Riëm El Tahry, Tine Wyckhuys, Veerle De Herdt, Evelien Carrette, Wytse Wadman, Yvette Michotte, Ilse Smolders, Paul Boon, Alfred Meurs
JournalJournal of neurochemistry (J Neurochem) Vol. 117 Issue 3 Pg. 461-9 (May 2011) ISSN: 1471-4159 [Electronic] England
PMID21323924 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.
Chemical References
  • Adrenergic alpha-Antagonists
  • Benzazepines
  • Muscarinic Agonists
  • Pilocarpine
  • benalfocin
  • Norepinephrine
Topics
  • Adrenergic alpha-Antagonists (pharmacology, therapeutic use)
  • Animals
  • Benzazepines (pharmacology, therapeutic use)
  • Disease Models, Animal
  • Electroencephalography
  • Hippocampus (drug effects, metabolism)
  • Male
  • Microdialysis (methods)
  • Muscarinic Agonists (adverse effects)
  • Norepinephrine (metabolism)
  • Pilocarpine (adverse effects)
  • Rats
  • Rats, Wistar
  • Seizures (chemically induced, pathology, therapy)
  • Statistics as Topic
  • Vagus Nerve Stimulation (methods)
  • Video Recording (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: